| Literature DB >> 19115029 |
Georgios Voidonikolas1, Stephanie S Kreml, Changyi Chen, William E Fisher, F Charles Brunicardi, Richard A Gibbs, Marie-Claude Gingras.
Abstract
The progress achieved in the field of genomics in recent years is leading medicine to adopt a personalized model in which the knowledge of individual DNA alterations will allow a targeted approach to cancer. Using pancreatic cancer as a model, we discuss herein the fundamentals that need to be considered for the high throughput and global identification of mutations. These include patient-related issues, sample collection, DNA isolation, gene selection, primer design, and sequencing techniques. We also describe the possible applications of the discovery of DNA changes to the approach of this disease and cite preliminary efforts where the knowledge has been translated into the clinical or preclinical setting.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19115029 PMCID: PMC2924149 DOI: 10.1007/s00268-008-9851-y
Source DB: PubMed Journal: World J Surg ISSN: 0364-2313 Impact factor: 3.352